EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Peptide Entry Inhibitors Targeting the Endosomal Receptor NPC1 Binding Site of Orthoebolavirus

Leah Liu Wang, Kendra Alfson iD, J J Patten iD, Marc E Mattix, Yenny Goez-Gazi, Sean N Avedissian iD, Robert A Davey iD, Ricardo Carrion iD, Shi-Hua Xiang iD

Pathogens · 16.06.2026 · 15 (6) · 640

DOI: 10.3390/pathogens15060640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 16.06.2026. Verfasst von Leah Liu Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Veterinary Medicine and Biomedical Sciences, Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68588, USA. Hauptthemen laut MEDLINE: Virus Internalization, Peptides, Ebolavirus, Antiviral Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orthoebolavirus causes severe Ebola virus disease (EVD) and deadly outbreaks in humans. This infection occurs through macropinocytosis and trafficking to late endosomes or lysosomes that utilize the receptor Niemann–Pick C1 (NPC1) to enter the cell cytoplasm. We designed peptide inhibitors based on the NPC1 receptor to target the NPC1 binding site to block viral entry. The results indicated that the ligand-based peptide inhibitors showed potent inhibition activities in vitro studies against pseudotyped or replication-competent Orthoebolavirus. Therefore, we further evaluated one of them in a mouse model challenged with mice-adapted Ebola viruses, which showed some protection efficacy compared with the control group. This study suggests that ligand-based peptides are encouraging inhibitors in the development of inhibitors against Ebola virus infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus InternalizationPeptidesEbolavirusAntiviral AgentsAnimalsMiceNiemann-Pick C1 ProteinBinding SitesHumansHemorrhagic Fever, EbolaEndosomesIntracellular Signaling Peptides and ProteinsDisease Models, AnimalProtein Binding

Stichwörter der Autor:innen

Ebola virus disease (EVD)Niemann–Pick C1 (NPC1)Orthoebolavirus bundibugyoense (BDBV)Orthoebolavirus zairense (EBOV)entry inhibitorpeptidereceptor-binding site (RBS)

Substanzen

Niemann-Pick C1 ProteinPeptidesAntiviral AgentsIntracellular Signaling Peptides and ProteinsNPC1 protein, human

Autor:innen und Institutionen

  • School of Veterinary Medicine and Biomedical Sciences, Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68588, USA.
  • Texas Biomedical Research Institute, 8715 W. Military Drive, San Antonio, TX 78227, USA.
  • National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02115, USA.
  • Nonclinical Pathology Services, LLC, 5920 Clubhouse Pointe Dr., Medina, OH 44256, USA.
  • College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA.

ORCID-Profile: Kendra Alfson, J J Patten, Sean N Avedissian, Robert A Davey, Ricardo Carrion, Shi-Hua Xiang

Förderung

  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Wang, L. L., Alfson, K., Patten, J. J., Mattix, M. E., Goez-Gazi, Y., Avedissian, S. N., Davey, R. A., Carrion, R., & Xiang, S. H. (2026). Development of Peptide Entry Inhibitors Targeting the Endosomal Receptor NPC1 Binding Site of Orthoebolavirus. Pathogens, 15(6), 640. https://doi.org/10.3390/pathogens15060640

Vancouver

Wang LL, Alfson K, Patten JJ, Mattix ME, Goez-Gazi Y, Avedissian SN, et al. Development of Peptide Entry Inhibitors Targeting the Endosomal Receptor NPC1 Binding Site of Orthoebolavirus. Pathogens. 2026;15(6):640. doi:10.3390/pathogens15060640

BibTeX
@article{Wang2026,
  author = {Wang, Leah Liu and Alfson, Kendra and Patten, J J and Mattix, Marc E and Goez-Gazi, Yenny and Avedissian, Sean N and Davey, Robert A and Carrion, Ricardo and Xiang, Shi-Hua},
  title = {Development of Peptide Entry Inhibitors Targeting the Endosomal Receptor NPC1 Binding Site of Orthoebolavirus},
  journal = {Pathogens},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {640},
  doi = {10.3390/pathogens15060640}
}
Kostenlos starten →